Results 11 to 20 of about 1,230,752 (303)

Formation and clearance of TNF–TNF inhibitor complexes during TNF inhibitor treatment

open access: yesBritish Journal of Pharmacology, 2023
AbstractBackground and PurposeMillions of patients with inflammatory diseases are treated with tumour necrosis factor (TNF) inhibitors (TNFi). Individual treatment response varies, in part related to variable drug clearance. The role of TNF–TNFi complexes in clearance of the different TNFi is controversial.
Lea Catharina Berkhout   +13 more
openaire   +3 more sources

Transmembrane TNF (pro‐TNF) is palmitoylated [PDF]

open access: yesFEBS Letters, 2001
Human transmembrane tumor necrosis factor (pro‐TNF) was examined for protein acylation. The cDNA encoding pro‐TNF was expressed in both COS‐1 cells and Sf9 cells and metabolic labeling with [3H]myristic or [3H]palmitic acid was attempted. The 17 kDa mature TNF secreted from the transfected cells was not labeled, whereas the 26 kDa pro‐TNF was ...
Utsumi, Toshihiko   +6 more
openaire   +2 more sources

Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma

open access: yesOncoImmunology, 2020
Background Costimulatory molecules play significant roles in mounting anti-tumor immune responses, and antibodies targeting these molecules are recognized as promising adjunctive cancer immunotherapies.
Chaoqi Zhang   +8 more
doaj   +1 more source

Future Therapeutic Directions for Smac-Mimetics

open access: yesCells, 2020
It is well accepted that the ability of cancer cells to circumvent the cell death program that untransformed cells are subject to helps promote tumor growth.
Emma Morrish   +2 more
doaj   +1 more source

ERK-1 MAP kinase prevents TNF-induced apoptosis through bad phosphorylation and inhibition of bax translocation in HeLa cells [PDF]

open access: yes, 2009
Extracellular signal-regulated kinase (ERK) 1/2 signaling is involved in tumor cell survival through the regulation of Bcl-2 family members. To explore this further and to demonstrate the central role of the mitochondria in the ERK1/2 pathway we used the
Aventaggiato, Michele   +10 more
core   +1 more source

Anti-tumor necrosis factor-alpha therapy during murine Klebsiella pneumoniae bacteremia: increased mortality in the absence of liver injury. [PDF]

open access: yes, 2003
Klebsiella pneumoniae is a leading cause of gram-negative bacterial pneumonia, often resulting in bacteremia concurrent with the localized pulmonary infection.
Cogen, Anna L   +4 more
core   +1 more source

Anti-TNF Therapy

open access: yesMicrobiology Spectrum, 2016
ABSTRACTTumor necrosis factor (TNF) is one of the most important cytokines produced by macrophages. TNF is a very important component of host defense, released very rapidly after all types of injuries and stimuli. The kinetics of TNF release are short, and so it is perhaps not surprising that prolonged TNF production is associated with pathology.
Udalova   +6 more
openaire   +3 more sources

Enhancement of experimental metastasis by tumor necrosis factor [PDF]

open access: yes, 1993
The influence of endogenous and exogenous tumor necrosis factor (TNF) on metastasis was investigated in an experimental fibrosarcoma metastasis model.
Echtenacher, Bernd   +5 more
core   +2 more sources

Glucocorticoid-induced microRNA-511 protects against TNF by down-regulating TNFR1 [PDF]

open access: yes, 2015
TNF is a central actor during inflammation and a well-recognized drug target for inflammatory diseases. We found that the mouse strain SPRET/Ei, known for extreme and dominant resistance against TNF-induced shock, displays weak expression of TNF receptor
Dejager, Lien   +11 more
core   +1 more source

Chronic inflammation evoked by pathogenic stimulus during carcinogenesis

open access: yes4 open, 2019
A pathogenic (biological or chemical) stimulus is the earliest information received by a cell that can result in the disruption of homeostasis with consequent development of disease.
Brücher Björn L.D.M., Jamall Ijaz S.
doaj   +1 more source

Home - About - Disclaimer - Privacy